GR3031639T3 - Transdermal therapeutic systems for the administration of serotonin agonists - Google Patents

Transdermal therapeutic systems for the administration of serotonin agonists

Info

Publication number
GR3031639T3
GR3031639T3 GR990402728T GR990402728T GR3031639T3 GR 3031639 T3 GR3031639 T3 GR 3031639T3 GR 990402728 T GR990402728 T GR 990402728T GR 990402728 T GR990402728 T GR 990402728T GR 3031639 T3 GR3031639 T3 GR 3031639T3
Authority
GR
Greece
Prior art keywords
administration
transdermal therapeutic
therapeutic systems
serotonin agonists
active substances
Prior art date
Application number
GR990402728T
Other languages
English (en)
Inventor
Harald List
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of GR3031639T3 publication Critical patent/GR3031639T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GR990402728T 1993-05-06 1999-10-27 Transdermal therapeutic systems for the administration of serotonin agonists GR3031639T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4314976A DE4314976C1 (de) 1993-05-06 1993-05-06 Transdermale therapeutische Systeme zur Verabreichung von Wirkstoffen, Verfahren zu ihrer Herstellung und ihre Verwendung
PCT/EP1994/001280 WO1994026270A1 (de) 1993-05-06 1994-04-25 Transdermale therapeutische systeme zur verabreichung von serotoninagonisten

Publications (1)

Publication Number Publication Date
GR3031639T3 true GR3031639T3 (en) 2000-02-29

Family

ID=6487316

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990402728T GR3031639T3 (en) 1993-05-06 1999-10-27 Transdermal therapeutic systems for the administration of serotonin agonists

Country Status (20)

Country Link
EP (1) EP0697869B1 (el)
JP (1) JPH08509749A (el)
KR (1) KR960702306A (el)
AT (1) ATE183392T1 (el)
AU (1) AU686159B2 (el)
CA (1) CA2160776A1 (el)
CZ (1) CZ289395A3 (el)
DE (2) DE4314976C1 (el)
DK (1) DK0697869T3 (el)
ES (1) ES2138659T3 (el)
FI (1) FI955260A (el)
GR (1) GR3031639T3 (el)
HU (1) HUT74865A (el)
IL (1) IL109509A (el)
NO (1) NO954414L (el)
NZ (1) NZ265949A (el)
PL (1) PL179353B1 (el)
SK (1) SK138095A3 (el)
WO (1) WO1994026270A1 (el)
ZA (1) ZA942872B (el)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9509985A (pt) 1995-12-12 1998-11-03 Omeros Med Sys Inc Solução para irrigação e método para inibição de dor inflamação e esparmo
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US7235257B1 (en) * 1999-12-14 2007-06-26 Rohto Pharmaceutical Co., Ltd. Drugs for relieving hemicrania comprising 1-menthol and essential oils
US8329734B2 (en) 2009-07-27 2012-12-11 Afgin Pharma Llc Topical therapy for migraine
EP1435945B1 (en) * 2001-06-05 2008-08-13 Aung-din, Ronald Topical migraine therapy
US7332183B2 (en) 2002-12-26 2008-02-19 Pozen Inc. Multilayer dosage forms containing NSAIDs and triptans
EP1644004A4 (en) 2003-06-20 2010-10-06 Ronald Aung-Din LOCAL THERAPY FOR THE TREATMENT OF MIGRAINS, MUSCLE CLARIFICATIONS, MUSCLE SPASMS, SPASTICITY AND RELATED CONDITIONS
CA2633588A1 (en) * 2005-12-20 2007-08-23 Teikoku Pharma Usa, Inc. Methods of transdermally administering an indole serotonin receptor agonist and transdermal compositions for use in the same
CA2650412C (en) * 2006-04-13 2016-09-27 Nupathe, Inc. Transdermal methods and systems for the delivery of anti-migraine compounds
JP2011526889A (ja) 2008-06-30 2011-10-20 アフギン ファーマ，エルエルシー 局所局部的神経作用療法
EP2480197B1 (en) 2009-09-25 2015-11-11 Dr. Reddy's Laboratories Ltd. Formulations comprising triptan compounds
US11337962B2 (en) 2009-09-25 2022-05-24 Upsher-Smith Laboratories, Llc Formulations comprising triptan compounds
JP6216151B2 (ja) * 2013-04-19 2017-10-18 コスメディ製薬株式会社 親水性薬物のエマルジョンパッチ
AU2016226267A1 (en) 2015-03-02 2017-09-28 Afgin Pharma, Llc Topical regional neuro-affective therapy with cannabinoids
US10383816B2 (en) 2015-03-02 2019-08-20 Afgin Pharma, Llc Topical regional neuro-affective therapy with cannabinoid combination products
US20180049994A1 (en) 2016-08-16 2018-02-22 Afgin Pharma, Llc Topical regional neuro-affective therapy with caryophyllene

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US5288498A (en) * 1985-05-01 1994-02-22 University Of Utah Research Foundation Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
AU8072691A (en) * 1990-06-28 1992-01-23 Beecham Group Plc Pharmaceutical preparations
GB9103770D0 (en) * 1991-02-22 1991-04-10 Glaxo Group Ltd Chemical compounds
GB9104890D0 (en) * 1991-03-08 1991-04-24 Glaxo Group Ltd Compositions

Also Published As

Publication number Publication date
PL311591A1 (en) 1996-02-19
IL109509A (en) 1999-12-22
AU686159B2 (en) 1998-02-05
DK0697869T3 (da) 2000-03-20
FI955260A0 (fi) 1995-11-02
SK138095A3 (en) 1996-06-05
WO1994026270A1 (de) 1994-11-24
NO954414D0 (no) 1995-11-03
AU6648094A (en) 1994-12-12
CA2160776A1 (en) 1994-11-24
JPH08509749A (ja) 1996-10-15
ES2138659T3 (es) 2000-01-16
CZ289395A3 (en) 1996-04-17
EP0697869A1 (de) 1996-02-28
ATE183392T1 (de) 1999-09-15
DE4314976C1 (de) 1994-10-06
IL109509A0 (en) 1994-08-26
HUT74865A (en) 1997-02-28
PL179353B1 (en) 2000-08-31
KR960702306A (ko) 1996-04-27
NZ265949A (en) 1997-10-24
DE59408643D1 (de) 1999-09-23
EP0697869B1 (de) 1999-08-18
ZA942872B (en) 1995-07-06
NO954414L (no) 1995-11-03
HU9503167D0 (en) 1996-01-29
FI955260A (fi) 1995-11-17

Similar Documents

Publication Publication Date Title
GR3031639T3 (en) Transdermal therapeutic systems for the administration of serotonin agonists
MX9207263A (es) Sistema para el suministro de una substancia activa para la liberacion sostenida.
DE69527509D1 (de) Hydrogelformulierung mit gesteuerter freisetzung
AU4989997A (en) Soluble form osmotic dose delivery system
ZA9610729B (en) Transdermal device for the delivery of flurbiprofen.
NO911260L (no) Utleveringssystem for aromastoff og soetningsmiddel, samt fremgangsmaate for fremstilling av et slikt system.
HUP9800863A3 (en) Drug delivery system for two or more active substances
GT199700009A (es) Terapia combinada para la osteoporosis.
NO305906B1 (no) Adhesjonsreseptorantagonister, farmasöytiske preparater som inneholder slike forbindelser, samt anvendelse av forbindelsene til fremstilling av legemidler
NO991405L (no) Belagt partikkelformulering
WO1997037640A3 (en) Uniform drug delivery therapy
EP0369685A3 (en) Fluoxetine analog
IL105139A0 (en) Indole and indazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
DK1044064T3 (da) Overtrækningsindretning til granula til indtagelse ad oral vej
NZ308516A (en) Transdermal therapeutic system (tts) for administering testosterone
GEP20043157B (en) Medicament Against Migraine Recurrence
ZA963744B (en) Topical aciclovir preparation
IL96506A0 (en) Transdermal system for administering pharmaceutical compounds under ph control
CA2250844A1 (en) Anti-hiv composition comprising imidazole derivatives
ZA966083B (en) Agent for transdermal administration containing esters of 13-ethyl-17ß-hydroxy-11-methylene-18,19-dinor-17Ó-pregn-4-en-20-yn-3-one.
NO931208L (no) Formuleringer for transdermale kontraseptiver, samt fremgangsmaater og innretninger for tilfoersel av slike
MX9605190A (es) Forma de dosis efectiva para farmacos antiepilepticos.
MY108739A (en) Imidazole, triazole and tetrazole derivatives